Table 3 Summary of recommended baseline screening tests for chemotherapy
Chemotherapy category | Necessary baseline screening test |
|---|---|
Anthracycline, HER2-targeted therapy | TTE (all patients) NT-proBNP (for patients at very high risk) cTn (for patients at very high risk) |
Fluoropyrimidine | TTE (for patients with previous CVD) |
VEGF, RAF/MEK, and BTK inhibitors | TTE (for patients at very high risk) |
ICI | TTE (for patients at very high risk) NT-proBNP (all patients) cTn (all patients) |
CART-T and TIL therapies | TTE (for patients with previous CVD) NT-proBNP (all patients) cTn (all patients) |
HSCT | TTE (all patients) |
Proteasome inhibitor | TTE (all patients) NT-proBNP (for patients at very high risk) |